id	sid	eid	entity	type
ijpds-3133	1	1	rai et al	PERSON
ijpds-3133	1	2	1	CARDINAL
ijpds-3133	1	3	2 | jul – sep	TIME
ijpds-3133	1	4	2022	CARDINAL
ijpds-3133	1	5	indian	NORP
ijpds-3133	1	6	j pharm drug	PRODUCT
ijpds-3133	1	7	38	CARDINAL
ijpds-3133	1	8	raju maski1	PERSON
ijpds-3133	1	9	jitendra banweer2	PERSON
ijpds-3133	1	10	megha mishra3	PERSON
ijpds-3133	1	11	gaurav goyanar4	PERSON
ijpds-3133	1	12	1m	CARDINAL
ijpds-3133	1	13	2sagar	CARDINAL
ijpds-3133	1	14	m.p.	GPE
ijpds-3133	1	15	3associate	CARDINAL
ijpds-3133	1	16	m.p.	GPE
ijpds-3133	1	17	indore m.p	PERSON
ijpds-3133	1	18	raju maski	PERSON
ijpds-3133	1	19	sagar institute of research technology & science pharmacy	ORG
ijpds-3133	1	20	m.p.	GPE
ijpds-3133	3	1	today	DATE
ijpds-3133	4	1	first	ORDINAL
ijpds-3133	6	1	dynam	DATE
ijpds-3133	8	1	second	ORDINAL
ijpds-3133	9	1	1	CARDINAL
ijpds-3133	10	1	about 60 million	CARDINAL
ijpds-3133	11	1	2	CARDINAL
ijpds-3133	12	1	9%	PERCENT
ijpds-3133	12	2	27%	PERCENT
ijpds-3133	12	3	20 years	DATE
ijpds-3133	12	4	first	ORDINAL
ijpds-3133	12	5	3	CARDINAL
ijpds-3133	13	1	2010	DATE
ijpds-3133	13	2	an estimated 4.5	CARDINAL
ijpds-3133	13	3	3.9 million	CARDINAL
ijpds-3133	13	4	acg	ORG
ijpds-3133	14	1	5.9	CARDINAL
ijpds-3133	14	2	5.3 million	CARDINAL
ijpds-3133	14	3	the year 2020	DATE
ijpds-3133	14	4	2	CARDINAL
ijpds-3133	20	1	second	ORDINAL
ijpds-3133	20	2	nearly 70 million	CARDINAL
ijpds-3133	20	3	12%	PERCENT
ijpds-3133	21	1	2020	DATE
ijpds-3133	21	2	4 million	CARDINAL
ijpds-3133	21	3	americans	NORP
ijpds-3133	21	4	50%	PERCENT
ijpds-3133	21	5	approximately 120,000	CARDINAL
ijpds-3133	23	1	us	GPE
ijpds-3133	24	1	daily	DATE
ijpds-3133	25	1	40%	PERCENT
ijpds-3133	25	2	75%	PERCENT
ijpds-3133	25	3	five years	DATE
ijpds-3133	28	1	1	CARDINAL
ijpds-3133	28	2	2 | jul – sep	TIME
ijpds-3133	28	3	2022	CARDINAL
ijpds-3133	28	4	indian	NORP
ijpds-3133	28	5	j pharm drug	PRODUCT
ijpds-3133	28	6	39	CARDINAL
ijpds-3133	30	1	daily	DATE
ijpds-3133	31	1	8	CARDINAL
ijpds-3133	32	1	5	CARDINAL
ijpds-3133	34	1	1975	DATE
ijpds-3133	34	2	2020	DATE
ijpds-3133	34	3	english	LANGUAGE
ijpds-3133	37	1	9	CARDINAL
ijpds-3133	38	1	a few days	DATE
ijpds-3133	39	1	1976	DATE
ijpds-3133	40	1	0.5 to 2 mg	QUANTITY
ijpds-3133	40	2	32	CARDINAL
ijpds-3133	40	3	10	CARDINAL
ijpds-3133	41	1	6.25 ±	MONEY
ijpds-3133	41	2	0.5	CARDINAL
ijpds-3133	42	1	1.5	CARDINAL
ijpds-3133	42	2	8.14 ± 0.96	MONEY
ijpds-3133	42	3	5	CARDINAL
ijpds-3133	43	1	32 hours	TIME
ijpds-3133	46	1	11	CARDINAL
ijpds-3133	46	2	first	ORDINAL
ijpds-3133	47	1	10 to 15-sec	CARDINAL
ijpds-3133	47	2	60–90 min	QUANTITY
ijpds-3133	48	1	ocusertocusert	PERSON
ijpds-3133	48	2	armaly	GPE
ijpds-3133	48	3	rao	ORG
ijpds-3133	49	1	12	CARDINAL
ijpds-3133	49	2	alza corporation inc.	ORG
ijpds-3133	49	3	ocusert	PERSON
ijpds-3133	49	4	20 or 40	CARDINAL
ijpds-3133	49	5	7 days	DATE
ijpds-3133	50	1	between two	CARDINAL
ijpds-3133	51	1	zimmerman et al	PERSON
ijpds-3133	51	2	40	CARDINAL
ijpds-3133	51	3	20	CARDINAL
ijpds-3133	51	4	25.6 ± 5.6 mmhg	QUANTITY
ijpds-3133	52	1	iop	ORG
ijpds-3133	52	2	19.9 ± 3.9	MONEY
ijpds-3133	54	1	13	CARDINAL
ijpds-3133	55	1	pavan-langston et al	ORG
ijpds-3133	55	2	29	CARDINAL
ijpds-3133	55	3	20 or 40 μg/h	PERCENT
ijpds-3133	56	1	14	CARDINAL
ijpds-3133	57	1	ocusert	PERSON
ijpds-3133	58	1	15	CARDINAL
ijpds-3133	59	1	timolol	ORG
ijpds-3133	60	1	timolol	ORG
ijpds-3133	61	1	finne et al	PERSON
ijpds-3133	62	1	16	CARDINAL
ijpds-3133	62	2	1.0 ± 0.1 ng	MONEY
ijpds-3133	62	3	three hours	TIME
ijpds-3133	62	4	64 ± 9 μg/ml	MONEY
ijpds-3133	63	1	1.6-fold	CARDINAL
ijpds-3133	63	2	104 ± 8 μg/ml	MONEY
ijpds-3133	64	1	shieldcollagen	ORG
ijpds-3133	64	2	svyatoslav fyodorov	PERSON
ijpds-3133	65	1	17	CARDINAL
ijpds-3133	66	1	bloomfield et	PERSON
ijpds-3133	68	1	bloomfield et al	ORG
ijpds-3133	69	1	18	CARDINAL
ijpds-3133	72	1	agban et al	PERSON
ijpds-3133	73	1	19	CARDINAL
ijpds-3133	73	2	tio2	GPE
ijpds-3133	74	1	14 days	DATE
ijpds-3133	75	1	escalon ophthalmics inc.	ORG
ijpds-3133	75	2	1	CARDINAL
ijpds-3133	75	3	2	CARDINAL
ijpds-3133	76	1	2022	CARDINAL
ijpds-3133	76	2	indian	NORP
ijpds-3133	76	3	j pharm drug	PRODUCT
ijpds-3133	76	4	40	CARDINAL
ijpds-3133	77	1	1.9 mm	QUANTITY
ijpds-3133	77	2	between 25	CARDINAL
ijpds-3133	77	3	30 mm	QUANTITY
ijpds-3133	78	1	katz	ORG
ijpds-3133	78	2	blackman	ORG
ijpds-3133	79	1	20	CARDINAL
ijpds-3133	81	1	70%	PERCENT
ijpds-3133	81	2	two weeks	DATE
ijpds-3133	82	1	minidiscbawa et al	PERSON
ijpds-3133	83	1	21	CARDINAL
ijpds-3133	83	2	ots	ORG
ijpds-3133	83	3	4–5 mm	QUANTITY
ijpds-3133	85	1	ots	ORG
ijpds-3133	86	1	22	CARDINAL
ijpds-3133	87	1	20µm-thick	TIME
ijpds-3133	87	2	4	CARDINAL
ijpds-3133	87	3	0.7	CARDINAL
ijpds-3133	87	4	3to	ORDINAL
ijpds-3133	90	1	23	CARDINAL
ijpds-3133	91	1	inserta	GPE
ijpds-3133	91	2	24	CARDINAL
ijpds-3133	92	1	24 to 29 mm	QUANTITY
ijpds-3133	93	1	six months	DATE
ijpds-3133	94	1	2016	DATE
ijpds-3133	94	2	de souza	PERSON
ijpds-3133	97	1	30 days	DATE
ijpds-3133	98	1	25	CARDINAL
ijpds-3133	101	1	26	CARDINAL
ijpds-3133	102	1	hitoshi et al	PERSON
ijpds-3133	102	2	timolol	ORG
ijpds-3133	102	3	2	CARDINAL
ijpds-3133	102	4	2	CARDINAL
ijpds-3133	104	1	27	CARDINAL
ijpds-3133	105	1	kaufman	PERSON
ijpds-3133	106	1	31	CARDINAL
ijpds-3133	106	2	first	ORDINAL
ijpds-3133	106	3	2hydroxyethyl	CARDINAL
ijpds-3133	107	1	1974	DATE
ijpds-3133	107	2	hillman	ORG
ijpds-3133	108	1	1%	PERCENT
ijpds-3133	109	1	4%	PERCENT
ijpds-3133	109	2	32	CARDINAL
ijpds-3133	111	1	48	CARDINAL
ijpds-3133	112	1	timolol	ORG
ijpds-3133	113	1	up to 8 days	DATE
ijpds-3133	113	2	33	CARDINAL
ijpds-3133	114	1	li et al	PERSON
ijpds-3133	115	1	34	CARDINAL
ijpds-3133	115	2	timolol	ORG
ijpds-3133	115	3	pluronic f127	PERSON
ijpds-3133	116	1	pluronic f127	PERSON
ijpds-3133	118	1	10% to 40%	PERCENT
ijpds-3133	118	2	28	CARDINAL
ijpds-3133	120	1	10% and 40%	PERCENT
ijpds-3133	120	2	about 5	CARDINAL
ijpds-3133	120	3	400	CARDINAL
ijpds-3133	123	1	35	CARDINAL
ijpds-3133	124	1	up to 1 month	DATE
ijpds-3133	126	1	40–45 mm	QUANTITY
ijpds-3133	126	2	hourly	TIME
ijpds-3133	126	3	1	CARDINAL
ijpds-3133	126	4	2	CARDINAL
ijpds-3133	127	1	2022	CARDINAL
ijpds-3133	128	1	indian	NORP
ijpds-3133	128	2	j pharm drug	PRODUCT
ijpds-3133	128	3	41	CARDINAL
ijpds-3133	128	4	52	CARDINAL
ijpds-3133	130	1	36	CARDINAL
ijpds-3133	130	2	timolol	ORG
ijpds-3133	131	1	timolol	ORG
ijpds-3133	133	1	24	CARDINAL
ijpds-3133	133	2	9.41	CARDINAL
ijpds-3133	136	1	allergan	GPE
ijpds-3133	136	2	53	CARDINAL
ijpds-3133	139	1	daily	DATE
ijpds-3133	140	1	37	CARDINAL
ijpds-3133	142	1	vs101	ORG
ijpds-3133	142	2	one	CARDINAL
ijpds-3133	142	3	visci inc.	ORG
ijpds-3133	142	4	2014	DATE
ijpds-3133	143	1	38	CARDINAL
ijpds-3133	144	1	pcl	ORG
ijpds-3133	145	1	39	CARDINAL
ijpds-3133	146	1	50.1%	PERCENT
ijpds-3133	146	2	± 8.5%	PERCENT
ijpds-3133	146	3	140 days	DATE
ijpds-3133	147	1	ap-pcl	ORG
ijpds-3133	147	2	ap-pcl	ORG
ijpds-3133	148	1	40	CARDINAL
ijpds-3133	148	2	three months	DATE
ijpds-3133	151	1	41	CARDINAL
ijpds-3133	155	1	natarajan	PERSON
ijpds-3133	156	1	at least six months	DATE
ijpds-3133	156	2	4°	QUANTITY
ijpds-3133	156	3	at least one month	DATE
ijpds-3133	156	4	25°	QUANTITY
ijpds-3133	157	1	60%	PERCENT
ijpds-3133	157	2	two weeks	DATE
ijpds-3133	158	1	4.8 ± 1.5	MONEY
ijpds-3133	158	2	daily	DATE
ijpds-3133	158	3	2.5 ± 0.9 mmhg	QUANTITY
ijpds-3133	158	4	90 days	DATE
ijpds-3133	159	1	42	CARDINAL
ijpds-3133	160	1	monem	PERSON
ijpds-3133	163	1	43	CARDINAL
ijpds-3133	164	1	half	CARDINAL
ijpds-3133	165	1	44	CARDINAL
ijpds-3133	167	1	mehta et al	PERSON
ijpds-3133	167	2	timolol	ORG
ijpds-3133	168	1	45	CARDINAL
ijpds-3133	169	1	2amino-2	CARDINAL
ijpds-3133	169	2	1	CARDINAL
ijpds-3133	169	3	2 | jul – sep	TIME
ijpds-3133	169	4	2022	CARDINAL
ijpds-3133	170	1	indian	NORP
ijpds-3133	170	2	j pharm drug	PRODUCT
ijpds-3133	170	3	42	CARDINAL
ijpds-3133	170	4	46	CARDINAL
ijpds-3133	172	1	li	PERSON
ijpds-3133	173	1	47	CARDINAL
ijpds-3133	174	1	1.75	CARDINAL
ijpds-3133	175	1	zhao	PERSON
ijpds-3133	176	1	49	CARDINAL
ijpds-3133	179	1	mehta et al	PERSON
ijpds-3133	180	1	triphasic	CARDINAL
ijpds-3133	180	2	49	CARDINAL
ijpds-3133	181	1	1	CARDINAL
ijpds-3133	181	2	4-dioxane-2	QUANTITY
ijpds-3133	181	3	5	CARDINAL
ijpds-3133	181	4	50	CARDINAL
ijpds-3133	182	1	salama	PERSON
ijpds-3133	182	2	51	CARDINAL
ijpds-3133	182	3	up to 10 days	DATE
ijpds-3133	183	1	khan	PERSON
ijpds-3133	183	2	52	CARDINAL
ijpds-3133	184	1	90%	PERCENT
ijpds-3133	184	2	72	DATE
ijpds-3133	184	3	96.6%	PERCENT
ijpds-3133	184	4	12	CARDINAL
ijpds-3133	186	1	shokry	PERSON
ijpds-3133	187	1	54	CARDINAL
ijpds-3133	188	1	timolol	ORG
ijpds-3133	190	1	liao et al	PERSON
ijpds-3133	191	1	55	CARDINAL
ijpds-3133	192	1	36-day	DATE
ijpds-3133	192	2	21 days	DATE
ijpds-3133	193	1	nanoparticlesjung et al	PERSON
ijpds-3133	194	1	56	CARDINAL
ijpds-3133	194	2	pgt	ORG
ijpds-3133	195	1	timolol	ORG
ijpds-3133	195	2	30 days	DATE
ijpds-3133	196	1	50%	PERCENT
ijpds-3133	196	2	only 1–2%	PERCENT
ijpds-3133	197	1	pgt	PERSON
ijpds-3133	197	2	dimethacrylate nanoparticlesjung	PERSON
ijpds-3133	198	1	57	CARDINAL
ijpds-3133	198	2	pgt	ORG
ijpds-3133	199	1	3.5	CARDINAL
ijpds-3133	199	2	48–66%	PERCENT
ijpds-3133	201	1	1 to 2 h	PERCENT
ijpds-3133	201	2	about four weeks	DATE
ijpds-3133	202	1	hydroxymethyl methacrylate	ORG
ijpds-3133	203	1	xu	PERSON
ijpds-3133	204	1	58	CARDINAL
ijpds-3133	204	2	timolol	ORG
ijpds-3133	205	1	timolol	ORG
ijpds-3133	206	1	timolol	ORG
ijpds-3133	206	2	144	CARDINAL
ijpds-3133	206	3	120	CARDINAL
ijpds-3133	207	1	timolol	ORG
ijpds-3133	207	2	120	CARDINAL
ijpds-3133	208	1	59	CARDINAL
ijpds-3133	208	2	60	CARDINAL
ijpds-3133	209	1	pcl	ORG
ijpds-3133	210	1	61	CARDINAL
ijpds-3133	211	1	chiang et al	PERSON
ijpds-3133	212	1	62	CARDINAL
ijpds-3133	212	2	6 mmhg	QUANTITY
ijpds-3133	212	3	one month	DATE
ijpds-3133	213	1	35 days	DATE
ijpds-3133	214	1	63	CARDINAL
ijpds-3133	216	1	60 μm	QUANTITY
ijpds-3133	217	1	57%-100%	PERCENT
ijpds-3133	218	1	1	CARDINAL
ijpds-3133	218	2	2 | jul – sep	TIME
ijpds-3133	218	3	2022	CARDINAL
ijpds-3133	218	4	indian	NORP
ijpds-3133	218	5	j pharm drug	PRODUCT
ijpds-3133	218	6	43	CARDINAL
ijpds-3133	218	7	nearly zero	CARDINAL
ijpds-3133	218	8	over three months	DATE
ijpds-3133	219	1	otero therapeutics	ORG
ijpds-3133	220	1	30%	PERCENT
ijpds-3133	220	2	standard brimonidine	ORG
ijpds-3133	220	3	28 days	DATE
ijpds-3133	221	1	64	CARDINAL
ijpds-3133	222	1	xrenv515 pga	PERSON
ijpds-3133	224	1	6.7 ± 3.7 mmhg	QUANTITY
ijpds-3133	224	2	eleven months	DATE
ijpds-3133	225	1	19.5 mmhg	QUANTITY
ijpds-3133	225	2	the 11 months	DATE
ijpds-3133	225	3	68	CARDINAL
ijpds-3133	226	1	bimatoprost srbimatoprost sr	PERSON
ijpds-3133	226	2	4-month	DATE
ijpds-3133	226	3	69	CARDINAL
ijpds-3133	227	1	first	ORDINAL
ijpds-3133	227	2	bimatoprost sr	PERSON
ijpds-3133	227	3	30%	PERCENT
ijpds-3133	227	4	12-week	DATE
ijpds-3133	228	1	one year	DATE
ijpds-3133	229	1	daily	DATE
ijpds-3133	230	1	bimatoprost sr	PERSON
ijpds-3133	231	1	3	CARDINAL
ijpds-3133	231	2	6 months	DATE
ijpds-3133	232	1	second	ORDINAL
ijpds-3133	232	2	70	CARDINAL
ijpds-3133	233	1	103	CARDINAL
ijpds-3133	234	1	71	CARDINAL
ijpds-3133	235	1	the first week	DATE
ijpds-3133	236	1	~20%	PERCENT
ijpds-3133	236	2	two months	DATE
ijpds-3133	237	1	up to three months	DATE
ijpds-3133	237	2	72	CARDINAL
ijpds-3133	239	1	30 days	DATE
ijpds-3133	240	1	perera et al	PERSON
ijpds-3133	241	1	73	CARDINAL
ijpds-3133	241	2	100%	PERCENT
ijpds-3133	241	3	ten days	DATE
ijpds-3133	241	4	5.4–7.5	CARDINAL
ijpds-3133	243	1	90 days	DATE
ijpds-3133	243	2	90%	PERCENT
ijpds-3133	244	1	timolol	ORG
ijpds-3133	245	1	williams	PERSON
ijpds-3133	246	1	74	CARDINAL
ijpds-3133	247	1	5.7 mmhg	CARDINAL
ijpds-3133	248	1	60%	PERCENT
ijpds-3133	248	2	at least 5	CARDINAL
ijpds-3133	248	3	47%	PERCENT
ijpds-3133	248	4	at least 6	CARDINAL
ijpds-3133	249	1	22.3%	PERCENT
ijpds-3133	250	1	75	CARDINAL
ijpds-3133	252	1	96%	PERCENT
ijpds-3133	252	2	12 weeks	DATE
ijpds-3133	253	1	second	ORDINAL
ijpds-3133	253	2	92%	PERCENT
ijpds-3133	253	3	the 12th week	DATE
ijpds-3133	254	1	7 mm	QUANTITY
ijpds-3133	254	2	5	CARDINAL
ijpds-3133	256	1	the food and drug administration	ORG
ijpds-3133	256	2	fda	ORG
ijpds-3133	256	3	five	CARDINAL
ijpds-3133	257	1	pcl	ORG
ijpds-3133	257	2	76	CARDINAL
ijpds-3133	260	1	between 10 and 200	CARDINAL
ijpds-3133	262	1	jiang et al	PERSON
ijpds-3133	262	2	500	CARDINAL
ijpds-3133	263	1	45-fold	CARDINAL
ijpds-3133	263	2	77	CARDINAL
ijpds-3133	264	1	rai et al	PERSON
ijpds-3133	264	2	1	CARDINAL
ijpds-3133	264	3	2	CARDINAL
ijpds-3133	265	1	2022	CARDINAL
ijpds-3133	266	1	indian	NORP
ijpds-3133	266	2	j pharm drug	PRODUCT
ijpds-3133	266	3	44	CARDINAL
ijpds-3133	267	1	ocusert	PERSON
ijpds-3133	267	2	14	CARDINAL
ijpds-3133	269	1	more than 50%	PERCENT
ijpds-3133	269	2	27	CARDINAL
ijpds-3133	269	3	28	CARDINAL
ijpds-3133	271	1	timolol	ORG
ijpds-3133	271	2	29	CARDINAL
ijpds-3133	272	1	30	CARDINAL
ijpds-3133	275	1	a few months	DATE
ijpds-3133	277	1	65	CARDINAL
ijpds-3133	279	1	66	CARDINAL
ijpds-3133	281	1	67	CARDINAL
ijpds-3133	293	1	the day	DATE
ijpds-3133	294	1	1	CARDINAL
ijpds-3133	295	1	kingman s. glaucoma	PERSON
ijpds-3133	295	2	second	ORDINAL
ijpds-3133	296	1	bull world health	ORG
ijpds-3133	297	1	2004	DATE
ijpds-3133	297	2	82:887-88	DATE
ijpds-3133	298	1	2	CARDINAL
ijpds-3133	298	2	quigley ha	PERSON
ijpds-3133	299	1	2010	DATE
ijpds-3133	299	2	2020	DATE
ijpds-3133	300	1	j ophthalmol	PERSON
ijpds-3133	301	1	2006	DATE
ijpds-3133	301	2	90:262-67	DATE
ijpds-3133	302	1	3	CARDINAL
ijpds-3133	302	2	johnson	PERSON
ijpds-3133	305	1	2001	DATE
ijpds-3133	305	2	105:2099-104	DATE
ijpds-3133	306	1	4	CARDINAL
ijpds-3133	306	2	kumar s.	PERSON
ijpds-3133	307	1	j curr	PERSON
ijpds-3133	307	2	pract	GPE
ijpds-3133	308	1	2015	CARDINAL
ijpds-3133	308	2	9:33-37	DATE
ijpds-3133	309	1	5	CARDINAL
ijpds-3133	309	2	wilson cg	PERSON
ijpds-3133	309	3	zhu yp	PERSON
ijpds-3133	312	1	j ophthalmol	PERSON
ijpds-3133	313	1	2000	DATE
ijpds-3133	313	2	82:1131-34	DATE
ijpds-3133	314	1	6	CARDINAL
ijpds-3133	314	2	lee vh	PERSON
ijpds-3133	314	3	robinson jr.	PERSON
ijpds-3133	315	1	j ocul pharmacol	PERSON
ijpds-3133	316	1	2001	DATE
ijpds-3133	316	2	2:67-108	CARDINAL
ijpds-3133	317	1	wei g	PERSON
ijpds-3133	317	2	xu h	PERSON
ijpds-3133	319	1	2002	DATE
ijpds-3133	319	2	83:65-74	DATE
ijpds-3133	320	1	walt jg	PERSON
ijpds-3133	320	2	wilensky jt	PERSON
ijpds-3133	321	1	clin drug investig	ORG
ijpds-3133	321	2	2007	DATE
ijpds-3133	321	3	27(12):819-25	DATE
ijpds-3133	323	1	kumari	PERSON
ijpds-3133	323	2	sharma pk	PERSON
ijpds-3133	324	1	j adv pharm technol	PERSON
ijpds-3133	324	2	2010	DATE
ijpds-3133	324	3	1:291-96	DATE
ijpds-3133	325	1	10	CARDINAL
ijpds-3133	326	1	kass ma	PERSON
ijpds-3133	328	1	1976	DATE
ijpds-3133	328	2	15:1008-10	DATE
ijpds-3133	330	1	maichuk yf.	PERSON
ijpds-3133	331	1	lancet	ORG
ijpds-3133	332	1	2013	DATE
ijpds-3133	333	1	305:173	CARDINAL
ijpds-3133	334	1	rai et al	PERSON
ijpds-3133	334	2	1	CARDINAL
ijpds-3133	334	3	2 | jul – sep	TIME
ijpds-3133	334	4	2022	CARDINAL
ijpds-3133	334	5	indian	NORP
ijpds-3133	334	6	j pharm drug	PRODUCT
ijpds-3133	334	7	45 12	DATE
ijpds-3133	335	1	armaly mf	PERSON
ijpds-3133	335	2	rao kr	PERSON
ijpds-3133	338	1	2003	DATE
ijpds-3133	338	2	12:491-96	DATE
ijpds-3133	339	1	13	CARDINAL
ijpds-3133	340	1	worthen dm	ORG
ijpds-3133	340	2	zimmerman tj	PERSON
ijpds-3133	342	1	2010	DATE
ijpds-3133	344	1	14	CARDINAL
ijpds-3133	344	2	macoul kl	PERSON
ijpds-3133	344	3	pavan-langton d. pilocarpine	PERSON
ijpds-3133	346	1	2010	DATE
ijpds-3133	347	1	93:587-90	CARDINAL
ijpds-3133	347	2	15	CARDINAL
ijpds-3133	348	1	puustjarvi t. practical	PERSON
ijpds-3133	349	1	acta ophthalmol.	PERSON
ijpds-3133	350	1	2002	DATE
ijpds-3133	350	2	58:933-37	DATE
ijpds-3133	351	1	16	CARDINAL
ijpds-3133	352	1	finne u	PERSON
ijpds-3133	352	2	a. modification	PERSON
ijpds-3133	354	1	1990	DATE
ijpds-3133	354	2	65:1927	DATE
ijpds-3133	354	3	17	CARDINAL
ijpds-3133	355	1	tannebaum s	ORG
ijpds-3133	356	1	j am	PERSON
ijpds-3133	356	2	assoc	ORG
ijpds-3133	357	1	2006	DATE
ijpds-3133	357	2	66:652-54	CARDINAL
ijpds-3133	358	1	18	CARDINAL
ijpds-3133	359	1	bloomfield se	PERSON
ijpds-3133	359	2	miyata t	PERSON
ijpds-3133	359	3	dunn mw	PERSON
ijpds-3133	362	1	1978	DATE
ijpds-3133	362	2	96:885-87	DATE
ijpds-3133	363	1	19	CARDINAL
ijpds-3133	364	1	agban y	PERSON
ijpds-3133	364	2	lian j	PERSON
ijpds-3133	366	1	2016	CARDINAL
ijpds-3133	367	1	501:96	CARDINAL
ijpds-3133	367	2	20	CARDINAL
ijpds-3133	368	1	katz	PERSON
ijpds-3133	368	2	blackman wm	PERSON
ijpds-3133	370	1	j ophthalmol	PERSON
ijpds-3133	371	1	2010	DATE
ijpds-3133	371	2	83:728-34	DATE
ijpds-3133	373	1	bawa r	PERSON
ijpds-3133	373	2	nandu m. physico-chemical	PERSON
ijpds-3133	375	1	2002	DATE
ijpds-3133	375	2	11:724-28	DATE
ijpds-3133	376	1	22	CARDINAL
ijpds-3133	377	1	diestelhorst m	PERSON
ijpds-3133	377	2	krieglstein gk	PERSON
ijpds-3133	379	1	1994	DATE
ijpds-3133	379	2	18:1	CARDINAL
ijpds-3133	379	3	23	CARDINAL
ijpds-3133	380	1	birmingham	GPE
ijpds-3133	382	1	j clin pharmacol	PERSON
ijpds-3133	382	2	2000	DATE
ijpds-3133	382	3	33:603-09	DATE
ijpds-3133	383	1	24	CARDINAL
ijpds-3133	384	1	brandt jd	PERSON
ijpds-3133	384	2	sall k	PERSON
ijpds-3133	384	3	six months	DATE
ijpds-3133	386	1	2016	CARDINAL
ijpds-3133	386	2	123:1685-94	DATE
ijpds-3133	387	1	25	CARDINAL
ijpds-3133	387	2	de souza jf	PERSON
ijpds-3133	387	3	maia kn	PERSON
ijpds-3133	387	4	de oliveria	PERSON
ijpds-3133	387	5	patricio ps	PERSON
ijpds-3133	388	1	sci tech	ORG
ijpds-3133	389	1	2016	CARDINAL
ijpds-3133	389	2	32:21-30	DATE
ijpds-3133	390	1	26	CARDINAL
ijpds-3133	391	1	stewart rh	PERSON
ijpds-3133	391	2	novak s. introduction	PERSON
ijpds-3133	392	1	2000	DATE
ijpds-3133	392	2	10:325-30	DATE
ijpds-3133	393	1	27	CARDINAL
ijpds-3133	394	1	hitoshi s	ORG
ijpds-3133	396	1	2001	DATE
ijpds-3133	396	2	27:127-37	DATE
ijpds-3133	398	1	li cc	PERSON
ijpds-3133	398	2	chauhan a.	PERSON
ijpds-3133	400	1	2006	DATE
ijpds-3133	400	2	45:3718-34	DATE
ijpds-3133	400	3	29	CARDINAL
ijpds-3133	401	1	peng cc	PERSON
ijpds-3133	401	2	kim j	PERSON
ijpds-3133	401	3	chauhan a.	PERSON
ijpds-3133	403	1	2010	DATE
ijpds-3133	403	2	31:4032-47	CARDINAL
ijpds-3133	404	1	30	CARDINAL
ijpds-3133	405	1	leobandung w	GPE
ijpds-3133	407	1	2000	DATE
ijpds-3133	407	2	50:27-46	DATE
ijpds-3133	408	1	31	CARDINAL
ijpds-3133	409	1	hiratani h	ORG
ijpds-3133	409	2	alvarez-lorenzo	PERSON
ijpds-3133	409	3	c. timolol	PERSON
ijpds-3133	411	1	2002	DATE
ijpds-3133	411	2	83:223-30	DATE
ijpds-3133	412	1	32	CARDINAL
ijpds-3133	413	1	waltman sr	PERSON
ijpds-3133	413	2	kaufman	PERSON
ijpds-3133	415	1	2008	DATE
ijpds-3133	415	2	9:250	CARDINAL
ijpds-3133	416	1	33	CARDINAL
ijpds-3133	417	1	hillman	ORG
ijpds-3133	420	1	j ophthalmol	PERSON
ijpds-3133	421	1	2009	DATE
ijpds-3133	421	2	58:674-79	CARDINAL
ijpds-3133	422	1	34	CARDINAL
ijpds-3133	423	1	chauhan a.	PERSON
ijpds-3133	425	1	2005	DATE
ijpds-3133	426	1	292:95	CARDINAL
ijpds-3133	427	1	li cc	PERSON
ijpds-3133	427	2	kapoor	PERSON
ijpds-3133	427	3	timolol	ORG
ijpds-3133	428	1	sci	ORG
ijpds-3133	428	2	2007	DATE
ijpds-3133	428	3	315:297	CARDINAL
ijpds-3133	429	1	36	CARDINAL
ijpds-3133	429	2	ciolino jb	PERSON
ijpds-3133	429	3	ross ae	PERSON
ijpds-3133	430	1	a month	DATE
ijpds-3133	432	1	2014	DATE
ijpds-3133	432	2	35:432-39	DATE
ijpds-3133	433	1	37	CARDINAL
ijpds-3133	434	1	kim hj	PERSON
ijpds-3133	434	2	zhang k	PERSON
ijpds-3133	436	1	2014	DATE
ijpds-3133	436	2	8:2998-3005	CARDINAL
ijpds-3133	437	1	38	CARDINAL
ijpds-3133	440	1	085	CARDINAL
ijpds-3133	441	1	39	CARDINAL
ijpds-3133	443	1	1/2	CARDINAL
ijpds-3133	445	1	ng xw	PERSON
ijpds-3133	445	2	liu kl	PERSON
ijpds-3133	447	1	2015	CARDINAL
ijpds-3133	447	2	5	CARDINAL
ijpds-3133	447	3	469–479	CARDINAL
ijpds-3133	448	1	41	CARDINAL
ijpds-3133	450	1	wehrung	GPE
ijpds-3133	450	2	ea	CARDINAL
ijpds-3133	451	1	eur j pharm biopharm 2016	ORG
ijpds-3133	451	2	107	CARDINAL
ijpds-3133	451	3	56–66	CARDINAL
ijpds-3133	451	4	42	CARDINAL
ijpds-3133	452	1	saati s	ORG
ijpds-3133	452	2	li p-y	PERSON
ijpds-3133	454	1	2009	DATE
ijpds-3133	454	2	107	CARDINAL
ijpds-3133	454	3	60–70	CARDINAL
ijpds-3133	455	1	43	CARDINAL
ijpds-3133	456	1	natarajan jv	PERSON
ijpds-3133	456	2	nanomedicine	PERSON
ijpds-3133	457	1	j nanomedicine	PERSON
ijpds-3133	458	1	2012	DATE
ijpds-3133	458	2	7	CARDINAL
ijpds-3133	458	3	123–131 44	DATE
ijpds-3133	459	1	monem	PERSON
ijpds-3133	459	2	ali fm	PERSON
ijpds-3133	459	3	ismail mw	PERSON
ijpds-3133	461	1	2000	CARDINAL
ijpds-3133	461	2	198	CARDINAL
ijpds-3133	461	3	29–38.	DATE
ijpds-3133	462	1	45	CARDINAL
ijpds-3133	463	1	zarbin ma	PERSON
ijpds-3133	463	2	leary jf	PERSON
ijpds-3133	464	1	j ophthalmol	PERSON
ijpds-3133	465	1	2010	DATE
ijpds-3133	465	2	45	CARDINAL
ijpds-3133	465	3	457–476	CARDINAL
ijpds-3133	465	4	46	DATE
ijpds-3133	466	1	mehta p	PERSON
ijpds-3133	466	2	al-kinani	PERSON
ijpds-3133	466	3	haj-ahmad	PERSON
ijpds-3133	467	1	eur j pharm biopharm 2017	ORG
ijpds-3133	467	2	119	CARDINAL
ijpds-3133	467	3	170–184	CARDINAL
ijpds-3133	469	1	ibrahim ka	PERSON
ijpds-3133	469	2	abu-sbeih	PERSON
ijpds-3133	469	3	chito	PERSON
ijpds-3133	470	1	mar drugs 2016	DATE
ijpds-3133	470	2	14	CARDINAL
ijpds-3133	470	3	43	CARDINAL
ijpds-3133	471	1	li j	PERSON
ijpds-3133	471	2	tao	PERSON
ijpds-3133	472	1	j nanomedicine	PERSON
ijpds-3133	473	1	2018	DATE
ijpds-3133	474	1	13	CARDINAL
ijpds-3133	474	2	3975–87	CARDINAL
ijpds-3133	475	1	49	DATE
ijpds-3133	476	1	zhao r	PERSON
ijpds-3133	476	2	li j	PERSON
ijpds-3133	476	3	wang j	PERSON
ijpds-3133	477	1	sci tech	ORG
ijpds-3133	478	1	2017	CARDINAL
ijpds-3133	478	2	18	CARDINAL
ijpds-3133	479	1	50	CARDINAL
ijpds-3133	480	1	mehta p	PERSON
ijpds-3133	480	2	al-kinani aa	PERSON
ijpds-3133	480	3	arshad ms	PERSON
ijpds-3133	481	1	sci	ORG
ijpds-3133	481	2	2019	DATE
ijpds-3133	481	3	108	CARDINAL
ijpds-3133	481	4	1540–51	CARDINAL
ijpds-3133	481	5	1	CARDINAL
ijpds-3133	481	6	2 | jul – sep	TIME
ijpds-3133	481	7	2022	CARDINAL
ijpds-3133	481	8	indian	NORP
ijpds-3133	481	9	j pharm drug	PRODUCT
ijpds-3133	481	10	46 51	DATE
ijpds-3133	482	1	di stefano	PERSON
ijpds-3133	484	1	2013	DATE
ijpds-3133	484	2	172	CARDINAL
ijpds-3133	484	3	436–43	CARDINAL
ijpds-3133	485	1	salama ha	PERSON
ijpds-3133	485	2	mahmoud aa	PERSON
ijpds-3133	486	1	sci tech	ORG
ijpds-3133	487	1	2017	CARDINAL
ijpds-3133	487	2	18	CARDINAL
ijpds-3133	487	3	2517–28	CARDINAL
ijpds-3133	488	1	53	DATE
ijpds-3133	488	2	khan n	FAC
ijpds-3133	488	3	ameeduzzafar	PERSON
ijpds-3133	488	4	khanna k	PERSON
ijpds-3133	490	1	2018	DATE
ijpds-3133	490	2	116	CARDINAL
ijpds-3133	491	1	648–663	CARDINAL
ijpds-3133	492	1	54	DATE
ijpds-3133	493	1	caprioli	PERSON
ijpds-3133	493	2	sears m. forskolin	PERSON
ijpds-3133	494	1	lancet	ORG
ijpds-3133	495	1	2012	DATE
ijpds-3133	495	2	1	CARDINAL
ijpds-3133	495	3	958–60	CARDINAL
ijpds-3133	496	1	55	CARDINAL
ijpds-3133	497	1	shokry m	PERSON
ijpds-3133	497	2	hathout rm	PERSON
ijpds-3133	497	3	mansour s.	PERSON
ijpds-3133	499	1	2018	DATE
ijpds-3133	500	1	545	CARDINAL
ijpds-3133	500	2	229–239	CARDINAL
ijpds-3133	501	1	liao y	PERSON
ijpds-3133	501	2	te lee ch	PERSON
ijpds-3133	501	3	chen st	PERSON
ijpds-3133	502	1	2017	CARDINAL
ijpds-3133	502	2	5	CARDINAL
ijpds-3133	502	3	7008–13	CARDINAL
ijpds-3133	502	4	jung hj	PERSON
ijpds-3133	502	5	timolol	ORG
ijpds-3133	503	1	2013	DATE
ijpds-3133	503	2	165	CARDINAL
ijpds-3133	503	3	82–89	CARDINAL
ijpds-3133	504	1	58	DATE
ijpds-3133	504	2	jung hj	PERSON
ijpds-3133	504	3	chauhan a.	PERSON
ijpds-3133	506	1	2012	DATE
ijpds-3133	506	2	33	CARDINAL
ijpds-3133	506	3	2289–300	CARDINAL
ijpds-3133	508	1	xu j	PERSON
ijpds-3133	508	2	ge y	PERSON
ijpds-3133	513	1	2019;305:18–28	CARDINAL
ijpds-3133	514	1	60	CARDINAL
ijpds-3133	516	1	conley s	PERSON
ijpds-3133	517	1	2008	DATE
ijpds-3133	517	2	48	CARDINAL
ijpds-3133	517	3	319–24	CARDINAL
ijpds-3133	518	1	61	CARDINAL
ijpds-3133	519	1	hillaireau h	ORG
ijpds-3133	521	1	2009	DATE
ijpds-3133	521	2	66	CARDINAL
ijpds-3133	521	3	2873–96	CARDINAL
ijpds-3133	522	1	62	CARDINAL
ijpds-3133	523	1	chiang b	PERSON
ijpds-3133	523	2	kim yc	PERSON
ijpds-3133	523	3	doty ac	PERSON
ijpds-3133	525	1	2016	CARDINAL
ijpds-3133	525	2	228	CARDINAL
ijpds-3133	526	1	48–57	CARDINAL
ijpds-3133	527	1	63	CARDINAL
ijpds-3133	528	1	malavia	PERSON
ijpds-3133	528	2	reddy l	ORG
ijpds-3133	529	1	2015	CARDINAL
ijpds-3133	529	2	56	CARDINAL
ijpds-3133	529	3	1296	CARDINAL
ijpds-3133	530	1	64	DATE
ijpds-3133	530	2	conner ip	PERSON
ijpds-3133	530	3	schuman	PERSON
ijpds-3133	531	1	sci rep.	ORG
ijpds-3133	531	2	2017	CARDINAL
ijpds-3133	531	3	7	CARDINAL
ijpds-3133	531	4	8639	CARDINAL
ijpds-3133	533	1	mansoor s	PERSON
ijpds-3133	533	2	kuppermann bd	PERSON
ijpds-3133	533	3	kenney mc	PERSON
ijpds-3133	533	4	intraocular sustainedrelease	PERSON
ijpds-3133	534	1	2009	DATE
ijpds-3133	534	2	26	CARDINAL
ijpds-3133	534	3	770–84	CARDINAL
ijpds-3133	535	1	66	CARDINAL
ijpds-3133	536	1	okabe k	PERSON
ijpds-3133	538	1	2003	DATE
ijpds-3133	538	2	44	DATE
ijpds-3133	538	3	2702–07	CARDINAL
ijpds-3133	539	1	67	CARDINAL
ijpds-3133	540	1	bao w	PERSON
ijpds-3133	540	2	zhou j	PERSON
ijpds-3133	540	3	luo j	PERSON
ijpds-3133	541	1	j micro	PERSON
ijpds-3133	542	1	2006	DATE
ijpds-3133	542	2	23:471-79	DATE
ijpds-3133	543	1	68	CARDINAL
ijpds-3133	545	1	2019	DATE
ijpds-3133	546	1	69	CARDINAL
ijpds-3133	547	1	allergan	PERSON
ijpds-3133	547	2	3	CARDINAL
ijpds-3133	548	1	70	CARDINAL
ijpds-3133	551	1	71	CARDINAL
ijpds-3133	551	2	hoang bp	PERSON
ijpds-3133	551	3	crean cs	PERSON
ijpds-3133	551	4	yang ml	PERSON
ijpds-3133	553	1	2018	DATE
ijpds-3133	553	2	59	CARDINAL
ijpds-3133	553	3	5710	CARDINAL
ijpds-3133	554	1	72	DATE
ijpds-3133	555	1	gebhart f. drug-delivery	PERSON
ijpds-3133	557	1	2017	CARDINAL
ijpds-3133	557	2	2:35-42	DATE
ijpds-3133	559	1	perera sa	PERSON
ijpds-3133	559	2	ting dsw	PERSON
ijpds-3133	560	1	asian	NORP
ijpds-3133	561	1	clin ophthalmol	PERSON
ijpds-3133	562	1	2016	CARDINAL
ijpds-3133	562	2	10	CARDINAL
ijpds-3133	562	3	757–64	CARDINAL
ijpds-3133	563	1	74	CARDINAL
ijpds-3133	564	1	goldberg df	PERSON
ijpds-3133	564	2	williams r.a.	PERSON
ijpds-3133	564	3	2	CARDINAL
ijpds-3133	566	1	2019	CARDINAL
ijpds-3133	566	2	22:13448	CARDINAL
ijpds-3133	567	1	75	CARDINAL
ijpds-3133	568	1	william r.	PERSON
ijpds-3133	569	1	2018	DATE
ijpds-3133	569	2	59	CARDINAL
ijpds-3133	569	3	5675	CARDINAL
ijpds-3133	570	1	76	DATE
ijpds-3133	572	1	sci tech	ORG
ijpds-3133	573	1	2015;16	CARDINAL
ijpds-3133	574	1	327–43	CARDINAL
ijpds-3133	575	1	77	DATE
ijpds-3133	575	2	shafiee	ORG
ijpds-3133	575	3	bowman lm	PERSON
ijpds-3133	575	4	hou e	PERSON
ijpds-3133	576	1	0.03%	PERCENT
ijpds-3133	577	1	clin ophthalmol	PERSON
ijpds-3133	578	1	2013;7:1549	CARDINAL
ijpds-3133	580	1	jiang j	PERSON
ijpds-3133	580	2	gill hs	PERSON
ijpds-3133	582	1	2007	DATE
ijpds-3133	582	2	48	DATE
ijpds-3133	582	3	4038	CARDINAL
ijpds-3133	582	4	43	DATE
ijpds-3133	583	1	castro	PERSON
ijpds-3133	583	2	brar j	PERSON
ijpds-3133	584	1	indian	NORP
ijpds-3133	584	2	2022	CARDINAL
ijpds-3133	584	3	1(2	DATE
ijpds-3133	584	4	38	CARDINAL